Bruker Corp (BRKR)
59.35
+0.06
(+0.10%)
USD |
NASDAQ |
Nov 04, 16:00
58.00
-1.35
(-2.27%)
After-Hours: 20:00
Bruker Revenue (Quarterly): 800.70M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 800.70M |
| March 31, 2024 | 721.70M |
| December 31, 2023 | 854.50M |
| September 30, 2023 | 742.80M |
| June 30, 2023 | 681.90M |
| March 31, 2023 | 685.30M |
| December 31, 2022 | 708.40M |
| September 30, 2022 | 638.90M |
| June 30, 2022 | 588.40M |
| March 31, 2022 | 595.00M |
| December 31, 2021 | 683.50M |
| September 30, 2021 | 608.90M |
| June 30, 2021 | 570.80M |
| March 31, 2021 | 554.70M |
| December 31, 2020 | 627.50M |
| September 30, 2020 | 511.40M |
| June 30, 2020 | 424.60M |
| March 31, 2020 | 424.00M |
| December 31, 2019 | 599.90M |
| September 30, 2019 | 521.10M |
| June 30, 2019 | 490.20M |
| March 31, 2019 | 461.40M |
| December 31, 2018 | 553.60M |
| September 30, 2018 | 466.60M |
| June 30, 2018 | 443.70M |
| Date | Value |
|---|---|
| March 31, 2018 | 431.70M |
| December 31, 2017 | 530.50M |
| September 30, 2017 | 435.60M |
| June 30, 2017 | 414.90M |
| March 31, 2017 | 384.90M |
| December 31, 2016 | 470.30M |
| September 30, 2016 | 393.90M |
| June 30, 2016 | 371.70M |
| March 31, 2016 | 375.40M |
| December 31, 2015 | 478.20M |
| September 30, 2015 | 396.10M |
| June 30, 2015 | 396.00M |
| March 31, 2015 | 353.50M |
| December 31, 2014 | 508.00M |
| September 30, 2014 | 419.80M |
| June 30, 2014 | 457.40M |
| March 31, 2014 | 423.70M |
| December 31, 2013 | 552.10M |
| September 30, 2013 | 439.00M |
| June 30, 2013 | 454.90M |
| March 31, 2013 | 393.40M |
| December 31, 2012 | 517.30M |
| September 30, 2012 | 447.80M |
| June 30, 2012 | 420.70M |
| March 31, 2012 | 405.60M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
424.00M
Minimum
Mar 2020
854.50M
Maximum
Dec 2023
632.78M
Average
627.50M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 649.73M |
| Azenta Inc | 172.81M |
| Harvard Bioscience Inc | 23.10M |
| Bionano Genomics Inc | 7.771M |
| Akoya Biosciences Inc | 23.16M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 7.60M |
| Total Expenses (Quarterly) | 729.30M |
| EPS Diluted (Quarterly) | 0.05 |
| Enterprise Value | 11.01B |
| Gross Profit Margin (Quarterly) | 48.03% |
| Profit Margin (Quarterly) | 0.95% |
| Earnings Yield | 4.06% |
| Operating Earnings Yield | 4.78% |
| Normalized Earnings Yield | 3.319 |